Irinot 100mg Injection
Marketer
Khandelwal Laboratories Pvt Ltd
Salt Composition
Irinotecan (100mg)
Overview Irinot 100mg Injection
Oncaspar 100mg Injection combats colorectal cancer by inhibiting or retarding cancerous cell proliferation. Administered intravenously by a healthcare professional, dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's prescribed regimen; improper usage or overdose may lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include tiredness, nausea, vomiting, debility, and alopecia. This medication can lower blood cell counts (red and white blood cells), increasing infection risk. Report fever, sore throat, or persistent diarrhea immediately. Regular blood tests monitoring blood cell counts, cardiac function, liver health, and uric acid levels are essential. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, and all medications, particularly those combating infections, as drug interactions are possible. This injection is contraindicated during pregnancy and lactation; effective contraception for both partners is crucial throughout treatment.
Uses of Irinot 100mg Injection
Colorectal cancer
Major Benefits of Irinot 100mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Irinot 100mg Injection:
- Fatigue
- Nausea
- Vomiting
- Weakness
- Hair loss
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Decreased appetite
- Mucosal inflammation
How to use Irinot 100mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Irinot 100mg Injection works:
Irinot 100mg Injection is a cancer treatment that inhibits topoisomerase I, a crucial enzyme in cancer cell DNA replication. This inhibition reduces cancer cell proliferation, ultimately leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Irinotecan 100mg Injection lacks established safety data. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Irinot 100mg Injection to pregnant individuals poses a confirmed risk to the fetus. Therefore, its use during pregnancy is contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem the potential benefits outweigh the hazards, necessitating a case-by-case assessment. Always seek medical advice.
Breast feedingUNSAFE
Administering Irinot 100mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
The Irinot 100mg Injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Refrain from driving if you experience these side effects.
KidneySAFE IF PRESCRIBED
Irinotecan 100mg injection appears to pose minimal risk for individuals with kidney impairment. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is advised. This medication is contraindicated for dialysis patients.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Irinot 100mg Injection to individuals with hepatic impairment. Seek medical advice from your physician.
What if you forget to take Irinot 100mg Injection :
Omit a dose of Irinot 100mg Injection? Seek your physician's advice.
Facts to Know About Irinot 100mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Camptothecin Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Topoisomerase inhibitor |
3,018 People bought this recently